Literature DB >> 26166768

Transcription factor IRF8 controls Th1-like regulatory T-cell function.

Wonyong Lee1, Hyeong Su Kim1, Song Yi Baek1, Gap Ryol Lee1.   

Abstract

Recent studies have suggested that regulatory T (Treg) cells comprise a heterogeneous population that regulates various aspects of the immune response, and that Treg cells use the factors that are expressed in their target cells to regulate them. We searched for factors that regulate Th1 response in Treg cells using a meta-analysis. In the process, we discovered that transcription factor interferon regulatory factor 8 (IRF8) was selectively expressed in Treg and Th1 cells. IRF8-deficient Treg cells showed defective expression of CXCR3 and aberrant expression of the Il4 and Il17 genes. Upon treatment with alpha galactosyl-C18-ceramide (αGal-C18-Cer), IRF8-deficient mice showed defective Treg cell recruitment in the liver. Eliciting Th1 immune response by anti-CD40 antibody injection in mice induced IRF8 expression in Treg cells. The expression of IRF8 was induced by Foxp3 in Treg cells. IRF8 had no effect on T-bet expression in Treg and vice versa. Thus, our results strongly suggest that IRF8 controls Th1 immune response in Treg cells independent of T-bet.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26166768      PMCID: PMC5101446          DOI: 10.1038/cmi.2015.72

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  35 in total

Review 1.  Regulation of immunity and oncogenesis by the IRF transcription factor family.

Authors:  David Savitsky; Tomohiko Tamura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Cancer Immunol Immunother       Date:  2010-01-05       Impact factor: 6.968

2.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

3.  Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells.

Authors:  Fumi Miyagawa; Hong Zhang; Atshushi Terunuma; Keiko Ozato; Yutaka Tagaya; Stephen I Katz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-10       Impact factor: 11.205

4.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

5.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

6.  Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells.

Authors:  Hanna Grindebacke; Hanna Stenstad; Marianne Quiding-Järbrink; Jesper Waldenström; Ingegerd Adlerberth; Agnes E Wold; Anna Rudin
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

7.  ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Celine Gongora; Julio Aliberti; Caetano Reis e Sousa; Alan Sher; Keiko Ozato
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

8.  CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

Authors:  Nassima Redjimi; Caroline Raffin; Isabelle Raimbaud; Pascale Pignon; Junko Matsuzaki; Kunle Odunsi; Danila Valmori; Maha Ayyoub
Journal:  Cancer Res       Date:  2012-07-12       Impact factor: 12.701

9.  ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Sestili; Paola Borghi; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

10.  Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.

Authors:  T Scharton-Kersten; C Contursi; A Masumi; A Sher; K Ozato
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  14 in total

1.  An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.

Authors:  John D Klement; Amy V Paschall; Priscilla S Redd; Mohammed L Ibrahim; Chunwan Lu; Dafeng Yang; Esteban Celis; Scott I Abrams; Keiko Ozato; Kebin Liu
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

2.  IRF8: identity-keeper for suppressive Th1-like Treg cells.

Authors:  Gap Ryol Lee
Journal:  Cell Mol Immunol       Date:  2018-05-22       Impact factor: 11.530

3.  Insights on the crosstalk between dendritic cells and helper T cells in novel genetic etiology for mendelian susceptible mycobacterial disease.

Authors:  Emma Rey-Jurado; Magdalena S Pizarro-Ortega; Alexis M Kalergis
Journal:  Cell Mol Immunol       Date:  2018-11-07       Impact factor: 11.530

Review 4.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

5.  Th17 cell differentiation proceeds independently of IRF8.

Authors:  Dane M Newman; Patrick Sk Leung; Tracy L Putoczki; Stephen L Nutt; Erika Cretney
Journal:  Immunol Cell Biol       Date:  2016-05-03       Impact factor: 5.126

Review 6.  Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.

Authors:  Scott I Abrams; Colleen S Netherby; Danielle Y F Twum; Michelle N Messmer
Journal:  J Interferon Cytokine Res       Date:  2016-07       Impact factor: 2.607

7.  Interferon Regulator Factor 8 (IRF8) Limits Ocular Pathology during HSV-1 Infection by Restraining the Activation and Expansion of CD8+ T Cells.

Authors:  Lin Sun; Anthony J St Leger; Cheng-Rong Yu; Chang He; Rashid M Mahdi; Chi-Chao Chan; Hongsheng Wang; Herbert C Morse; Charles E Egwuagu
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 8.  Dendritic cell analysis in primary immunodeficiency.

Authors:  Venetia Bigley; Dawn Barge; Matthew Collin
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-12

9.  IRF8-dependent molecular complexes control the Th9 transcriptional program.

Authors:  Etienne Humblin; Marion Thibaudin; Fanny Chalmin; Valentin Derangère; Emeric Limagne; Corentin Richard; Richard A Flavell; Sandy Chevrier; Sylvain Ladoire; Hélène Berger; Romain Boidot; Lionel Apetoh; Frédérique Végran; François Ghiringhelli
Journal:  Nat Commun       Date:  2017-12-12       Impact factor: 14.919

10.  Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.

Authors:  Venetia Bigley; Sheetal Maisuria; Urszula Cytlak; Laura Jardine; Matthew A Care; Kile Green; Merry Gunawan; Paul Milne; Rachel Dickinson; Sarah Wiscombe; David Parry; Rainer Doffinger; Arian Laurence; Claudia Fonseca; Oda Stoevesandt; Andrew Gennery; Andrew Cant; Reuben Tooze; A John Simpson; Sophie Hambleton; Sinisa Savic; Gina Doody; Matthew Collin
Journal:  J Allergy Clin Immunol       Date:  2017-11-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.